That they aren't in prison is a national disgrace.
That they aren't in prison is a national disgrace.
https://en.wikipedia.org/wiki/Sackler_family#History
Arthur, Mortimer, and Raymond Sackler, the three children of Jewish immigrants from Galicia and Poland, grew up in Brooklyn in the 1930s. All three of the siblings went to medical school and worked together at the Creedmoor Psychiatric Center in Queens. They were often cited as early pioneers in medication techniques which ended the common practice of lobotomies, and were also regarded as the first to fight for the racial integration of blood banks.[11] Arthur Sackler was widely regarded as the patriarch of the family. In 1952, the brothers bought a small pharmaceutical company, Purdue-Frederick.[12] Raymond and Mortimer ran Purdue, while Arthur, the oldest brother, became a pioneer in medical advertising. He devised campaigns appealing directly to doctors, and enlisted prominent physicians to endorse Purdue's products. As one of the foremost art collectors of his generation, he also donated the majority of his collections to museums around the world. After his death in 1987, his option on one third of Purdue-Frederick was sold by his estate to his two brothers who turned it into Purdue Pharma.
In 1996, Purdue Pharma introduced OxyContin, a reformulated version of oxycodone in a slow-release form. Oxycodone was first invented in 1916 and sold as Eukodal, but had been withdrawn from the market in 1990 due to addiction issues.[citation needed]
Heavily promoted,[14][15] oxycodone is a key drug in the emergence of the opioid epidemic.[16][17] Elizabeth Sackler, daughter of Arthur Sackler, claimed that her branch of the family did not participate in or benefit from the sales of narcotics. While some[who?] have criticized Arthur Sackler for pioneering marketing techniques to promote non-opioids decades earlier, Professor Evan Gerstmann said in Forbes magazine, "It is an absurd inversion of logic to say that because Arthur Sackler pioneered direct marketing to physicians, he is responsible for the fraudulent misuse of that technique, which occurred many years after his death and from which he procured no financial gain."[18][19][20] In 2018, multiple members of the Raymond and Mortimer Sackler families, Richard Sackler, Theresa Sackler, Kathe Sackler, Jonathan Sackler, Mortimer Sackler, Beverly Sackler, David Sackler, and Ilene Sackler, were all named as defendants in suits filed by numerous states over their involvement in the opioid crisis.[21][22]
In 2012, a member of the Sackler family bought Stargroves, a manor house near Newbury in the UK for more than its £15 million listing price; former owners at different times of the estate have been Mick Jagger and Rod Stewart.[23][24] The family was first listed in Forbes list of America's Richest Families in 2015.[25]
The Sackler family is also the owner of Mundipharma, a lower profile pharma company that has significant operations in China. Bloomberg News reported in 2020 that the family had hired an investment bank to identify a potential buyer of the business.[26] The company could fetch as much as $3 to $5 billion.[1]
https://en.wikipedia.org/wiki/Sackler_family#History
Arthur, Mortimer, and Raymond Sackler, the three children of Jewish immigrants from Galicia and Poland, grew up in Brooklyn in the 1930s. All three of the siblings went to medical school and worked together at the Creedmoor Psychiatric Center in Queens. They were often cited as early pioneers in medication techniques which ended the common practice of lobotomies, and were also regarded as the first to fight for the racial integration of blood banks.[11] Arthur Sackler was widely regarded as the patriarch of the family. In 1952, the brothers bought a small pharmaceutical company, Purdue-Frederick.[12] Raymond and Mortimer ran Purdue, while Arthur, the oldest brother, became a pioneer in medical advertising. He devised campaigns appealing directly to doctors, and enlisted prominent physicians to endorse Purdue's products. As one of the foremost art collectors of his generation, he also donated the majority of his collections to museums around the world. After his death in 1987, his option on one third of Purdue-Frederick was sold by his estate to his two brothers who turned it into Purdue Pharma.
In 1996, Purdue Pharma introduced OxyContin, a reformulated version of oxycodone in a slow-release form. Oxycodone was first invented in 1916 and sold as Eukodal, but had been withdrawn from the market in 1990 due to addiction issues.[citation needed]
Heavily promoted,[14][15] oxycodone is a key drug in the emergence of the opioid epidemic.[16][17] Elizabeth Sackler, daughter of Arthur Sackler, claimed that her branch of the family did not participate in or benefit from the sales of narcotics. While some[who?] have criticized Arthur Sackler for pioneering marketing techniques to promote non-opioids decades earlier, Professor Evan Gerstmann said in Forbes magazine, "It is an absurd inversion of logic to say that because Arthur Sackler pioneered direct marketing to physicians, he is responsible for the fraudulent misuse of that technique, which occurred many years after his death and from which he procured no financial gain."[18][19][20] In 2018, multiple members of the Raymond and Mortimer Sackler families, Richard Sackler, Theresa Sackler, Kathe Sackler, Jonathan Sackler, Mortimer Sackler, Beverly Sackler, David Sackler, and Ilene Sackler, were all named as defendants in suits filed by numerous states over their involvement in the opioid crisis.[21][22]
In 2012, a member of the Sackler family bought Stargroves, a manor house near Newbury in the UK for more than its £15 million listing price; former owners at different times of the estate have been Mick Jagger and Rod Stewart.[23][24] The family was first listed in Forbes list of America's Richest Families in 2015.[25]
The Sackler family is also the owner of Mundipharma, a lower profile pharma company that has significant operations in China. Bloomberg News reported in 2020 that the family had hired an investment bank to identify a potential buyer of the business.[26] The company could fetch as much as $3 to $5 billion.[1]
(post is archived)